医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Teleflex Responds to Haiyan Disaster Relief Efforts

2013年11月22日 AM07:25
このエントリーをはてなブックマークに追加


 

LIMERICK, Pa.

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, today announced an initial donation of $25,000 in support of disaster relief efforts in the Philippines. Teleflex is also organizing its global workforce to support this cause with donations that will be matched by the Teleflex Foundation.

Teleflex has identified the American Red Cross for its corporate grant, and it is also matching gifts of employees to other disaster relief agencies. Individual donations and group collections are taking place at Teleflex workplaces globally.

“Our purpose as a company is to improve the health and quality of peoples’ lives,” said Benson Smith, Chairman, President and Chief Executive Officer. “We feel a deep responsibility to be part of the effort to support the people of the Philippines as they recover from this tragedy, and we are challenging our employees to give whatever they can to this effort by committing an equal match from the company,” he added.

Working with health care providers in Asia, Teleflex has donated HudsonRCI Aquapak ® pre-filled humidifiers and nebulizers to support clinicians in the Philippines.

About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, PA, Teleflex employs approximately 11,200 people worldwide and serves healthcare providers in more than 140 countries. Additional information about Teleflex can be obtained from the company’s website at www.teleflex.com.

CONTACT

Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Takeda and Seattle Genetics to Present Positive Data from Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (brentuximab vedotin) in Frontline Advanced Hodgkin Lymphoma
  • Herbalife Nutrition Hong Kong and Po Leung Kuk Set New World Record in Launching Healthy Active Lifestyle Mobile App
  • Median Technologies Inks a Research Collaboration Agreement for Lung Cancer Screening Programs With Xingtai People’s Hospital, Xingtai City, China
  • Genentech’s HEMLIBRA (emicizumab-kxwh) Every Four Weeks Controlled Bleeds in Phase III Study in Hemophilia A
  • Orthocell Commences Treatment of Its 1,000th Patient